###begin article-title 0
Variations in the Ghrelin Receptor Gene Associate with Obesity and Glucose Metabolism in Individuals with Impaired Glucose Tolerance
###end article-title 0
###begin p 1
Conceived and designed the experiments: UM LP CC MU. Performed the experiments: UM TD. Analyzed the data: UM TD AMT. Contributed reagents/materials/analysis tools: LP MK JL JE CC JT MU. Wrote the paper: UM TD AMT. Read and commented on the paper: LP MK JL JE CC JT MU.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Ghrelin may influence the development of obesity through its role in the control of energy balance, food intake, and regulation of body weight. The effects of ghrelin are mediated via the growth hormone secretagogue receptor (GHSR).
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 331 340 331 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 466 474 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 674 686 674 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9819506-AA</italic>
###xml 744 755 744 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 1162 1172 1162 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rs490683-C</italic>
###xml 1250 1262 1250 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs4906863-GG</italic>
###xml 1323 1327 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 202 209 <span type="species:ncbi:9606">persons</span>
###xml 661 668 <span type="species:ncbi:9606">persons</span>
We genotyped 7 single nucleotide polymorphisms (SNPs) in the GHSR gene and assessed the association between those SNPs and obesity and type 2 diabetes-related phenotypes from 507 middle-aged overweight persons with impaired glucose tolerance participating in the Finnish Diabetes Prevention Study (DPS). Additionally, we performed in silico screening of the 5'-regulatory region of GHSR and evaluated SNPs disrupting putative transcription factor (TF) binding sites in vitro with gelshift assays to determine differences in protein binding between different alleles of SNPs. Rs9819506 in the promoter region of GHSR was associated with body weight (p = 0.036); persons with rs9819506-AA genotype having the lowest body weight. Individuals with rs490683-CC genotype displayed highest weight loss in the whole study population (p = 0.032). The false discovery rate for these results was <10%. Rs490683 and rs509035 were associated with several measures of glucose and insulin metabolism during the follow-up. Rs490683 may be a functional SNP, since gelshift experiments showed differential protein binding between the alleles, with higher binding to the G-allele. Rs490683-C may disrupt a putative binding site for the TF nuclear factor 1 (NF-1), thus rs4906863-GG genotype where the NF-1 site is intact may lead to a higher GHSR gene expression.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
Polymorphisms in the GHSR promoter may modify changes in body weight during long-term lifestyle intervention and affect ghrelin receptor signalling through modulation of GHSR gene expression.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Murphy1">[1]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Kojima1">[2]</xref>
###xml 412 415 412 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Kojima2">[3]</xref>
Ghrelin is predominantly produced by the stomach and is the only known orexigenic hormone and endogenous ligand for the growth-hormone-secretagogue receptor (GHSR) [1], [2]. Ghrelin is composed of 28 amino acids and is uniquely modified by the addition of an octanoyl group to the serine residue at position three. This acylation is necessary for ghrelin to bind to the GHSR and to cross the blood-brain barrier [3].
###end p 9
###begin p 10
###xml 48 51 48 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Kojima1">[2]</xref>
###xml 68 71 68 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Inui1">[4]</xref>
###xml 126 129 126 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Tschp1">[5]</xref>
###xml 131 134 131 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Nakazato1">[6]</xref>
###xml 374 377 374 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Holst1">[7]</xref>
###xml 444 447 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Willesen1">[8]</xref>
Ghrelin is implicated in growth hormone release [2], energy balance [4], food intake, and long-term regulation of body weight [5], [6]. A major target for ghrelin is the arcuate nucleus of the hypothalamus, where ghrelin acts on appetite-stimulating groups of neurons, which express the potent orexigenic neuropeptides neuropeptide Y (NPY) and agouti-related protein (AGRP) [7]. These NPY/AGRP-containing neurons also express ghrelin receptors [8].
###end p 10
###begin p 11
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Howard1">[9]</xref>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 289 292 289 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Howard1">[9]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-vanderLely1">[10]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Gnanapavan1">[11]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-vanderLely1">[10]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Hattori1">[12]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Dixit1">[13]</xref>
The GHSR gene, located on chromosome 3q26.31, encodes a protein that belongs to the family of G protein-coupled receptors [9]. Two distinct GHSR transcripts are known: GHSR type 1a acts as ghrelin receptor, whereas type 1b is a truncated form of the GHSR 1a and pharmacologically inactive [9]. GHSR 1a is expressed mainly in the hypothalamus and pituitary [10], [11], whereas the GHSR type 1b mRNA expression has also been found in many peripheral organs [10], including immune cells [12], [13], indicating that ghrelin may have multiple functions in these tissues but with thus far unknown importance.
###end p 11
###begin p 12
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 318 321 318 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Murphy1">[1]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Zigman1">[14]</xref>
###xml 110 114 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Models of disrupted ghrelin signalling can show complex energy homeostasis-related phenotypes. GHSR-deficient mice show resistance to diet-induced obesity when supplied with a high-fat diet early in life, which implicates that functional ghrelin signalling is required for the full development of diet-induced obesity [1], [14].
###end p 12
###begin p 13
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Baessler1">[15]</xref>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Baessler1">[15]</xref>
###xml 315 321 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Vartiainen1">[16]</xref>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Dossus1">[17]</xref>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Loos1">[18]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Frayling1">[19]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Scott1">[20]</xref>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Salonen1">[21]</xref>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 1112 1116 1112 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 1270 1274 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 1008 1020 <span type="species:ncbi:9606">participants</span>
In humans, the GHSR gene lies within a quantitative trait locus strongly linked to multiple phenotypes related to obesity and the metabolic syndrome [15]. Baessler et al. have described a "susceptible" and "non-susceptible" haplotype for obesity of five GHSR single nucleotide polymorphisms (SNPs) [15]. Vartiainen et al.[16] showed an association between insulin values and a GHSR variant. A recent study reports a weak association between one GHSR variant and BMI [17]. In recently conducted genome-wide association (GWA) studies, GHSR was not among the few genes associated with obesity [18], [19] or type 2 diabetes [20], [21]. Although GWA studies are very elegantly conducted to unravel the genetics of chronic diseases, candidate gene analyses also can often contribute to our knowledge about these disorders. Thus, we investigated SNPs in the GHSR gene and their association with obesity, glucose and insulin metabolism, and the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in participants of the Finnish Diabetes Prevention Study (DPS). We demonstrated an association between one GHSR promoter SNP and weight loss during a 3-year follow-up and consequently showed that this SNP might have functional consequences on the expression of the GHSR gene.
###end p 13
###begin title 14
Results
###end title 14
###begin p 15
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 140 147 140 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g001">Fig. 1A</xref>
###xml 290 297 290 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g001">Fig. 1B</xref>
We genotyped 7 SNPs in the GHSR gene, four of which are located in the 5'-region, one in exon 1, one intronic and one SNP in the 3'-region (Fig. 1A). Rs490683, which was associated with weight loss and measures of glucose metabolism, is in strong linkage disequilibrium (LD) with rs509035 (Fig. 1B).
###end p 15
###begin title 16
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human GHSR gene and location of SNPs and their LD measures.
###end title 16
###begin p 17
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 416 417 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 719 720 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 35 40 <span type="species:ncbi:9606">human</span>
A. Schematic representation of the human GHSR gene indicating the locations of analyzed single nucleotide polymorphisms (SNPs) that belong to two haploblocks. (black star), SNPs genotyped in the Finnish Diabetes Prevention Study population. # SNPs from HapMap database in transcription factor (TF) binding sites and tested in gelshift assays. B. Standardized pair-wise linkage disequilibria (LD) measures of D' and r2 for seven GHSR single nucleotide polymorphisms (SNPs) of the Finnish Diabetes Prevention Study. Major/minor alleles and the minor allele frequency (in parentheses) are included below each SNP identification number. For each cell, the number on the top line is D' and the number on the bottom line is r2. Strength of LD is indicated in greyscale with black denoting strong and white weak LD.
###end p 17
###begin title 18
Association with obesity-related phenotypes
###end title 18
###begin p 19
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002941-t001">Table 1</xref>
###xml 327 334 327 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g002">Fig. 2A</xref>
At baseline, no significant differences were observed between the genotypes of all seven SNPs for obesity-related traits (Table 1 for rs490683, data not shown for other SNPs). However, using repeated measures ANOVA we observed that during the 3-year follow-up weight was significantly different between genotypes of rs9819506 (Fig. 2A) and tended to differ for BMI (p/q = 0.056/0.041).
###end p 19
###begin title 20
Weight and weight loss according to rs9819506 and rs490683 genotypes in DPS.
###end title 20
###begin p 21
###xml 199 211 197 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9819506-GG</italic>
###xml 239 251 237 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9819506-GA</italic>
###xml 277 289 275 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9819506-AA</italic>
###xml 341 343 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 348 350 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 362 364 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 369 371 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 383 385 381 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 390 392 388 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 543 554 541 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 569 580 567 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CG</italic>
###xml 597 608 595 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-GG</italic>
A. Weight according to rs9819506 genotypes in the entire study population. Mean+/-SEM are estimated marginal means calculated from repeated measures ANOVA with sex and age as significant covariates. rs9819506-GG (n = 171, filled circles); rs9819506-GA (n = 200, open cirlces); rs9819506-AA (n = 59, filled triangles); pair-wise comparisons: GG vs. GA p = 1.000, GG vs. AA p = 0.030, GA vs. AA p = 0.116. B. Relative weight loss according to the different genotypes of rs490683 in all subjects and separately in intervention and control group. rs490683-CC (black bars); rs490683-CG (striped bars); rs490683-GG (white bars). The q-value denotes the false discovery rate (FDR) and is reported only for p<0.1. n.s., non-significant.
###end p 21
###begin title 22
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
Baseline characteristics of the DPS study subjects according to the rs490683 polymorphism of the GHSR gene.
###end title 22
###begin p 23
Values are means+/-SD; ANOVA for comparison among three genotype groups, adjusted for age, sex and BMI as main effects.
###end p 23
###begin p 24
p-value adjusted for age and sex.
###end p 24
###begin p 25
Chi-square Test.
###end p 25
###begin p 26
Kruskal-Wallis Test.
###end p 26
###begin p 27
FDR was >60% for all p-values.
###end p 27
###begin p 28
###xml 87 98 87 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g002">Fig. 2B</xref>
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g002">Fig. 2B</xref>
During the 3-year intervention. all subjects being analyzed together, individuals with rs490683-CC genotype lost significantly more weight than others (Fig. 2B). When the two intervention groups were analyzed separately, differences in weight loss according to the genotypes were only observed in the intervention group (Fig. 2B).
###end p 28
###begin p 29
No significant differences in weight loss during the intervention period were observed for other SNPs (data not shown).
###end p 29
###begin p 30
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g001">Fig. 1A</xref>
We carried out haplotype analysis with the 4 genotyped SNPs in haploblock 1 (rs6772676, rs474225, rs490683 and rs9819506, respectively; Fig. 1A). The haplotype analysis did not offer more information than the single SNP analysis, thus these results were not included in the current manuscript. Concerning weight, the G-allele of rs9819506 seems to be responsible for higher weight in all subjects. The haplotype analysis regarding weight change did not reveal any significant results, largely due to the fact that not all relevant haplotypes could be tested due to their low frequency (data not shown).
###end p 30
###begin title 31
Association with phenotypes related to glucose metabolism
###end title 31
###begin p 32
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 135 142 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002941-t001">Table 1</xref>
At baseline, no significant associations with measures of glucose metabolism and the seven genotyped GHSR polymorphisms were observed (Table 1 for rs490683, data not shown for other SNPs).
###end p 32
###begin p 33
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g003">Fig. 3A</xref>
###xml 431 442 431 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 691 707 691 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g003">Fig. 3B, C and E</xref>
###xml 907 916 907 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g003">Fig. 3B&#8211;E</xref>
###xml 1031 1042 1031 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 1686 1697 1686 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs509035-TT</italic>
###xml 1018 1025 <span type="species:ncbi:9606">persons</span>
###xml 1673 1680 <span type="species:ncbi:9606">persons</span>
Differences between genotypes were observed with the rs6772676 SNP for fasting (p/q = 0.038/0.035) and 2-h plasma glucose (p/q = 0.006/0.035), with heterozygotes having the highest levels in the whole study population when data were analyzed longitudinally. In similar analysis for rs490683, 2-h plasma glucose (Fig. 3A) and 2-h serum insulin levels (p/q = 0.050/0.041) differed significantly according to different genotypes with rs490683-CC subjects tending to have the lowest 2-h glucose and insulin levels throughout the follow-up. Three-year changes in fasting plasma glucose, 2-h plasma glucose and 2-h serum insulin in the entire study population differed between rs490683 genotypes (Fig. 3B, C and E, respectively). When the study groups were analyzed separately, significant differences were found between the rs490683 genotypes in fasting and 2-h plasma glucose and fasting and 2-h serum insulin (Fig. 3B-E) in the control group, but not in the intervention group. Levels of glucose and insulin decreased in persons with rs490683-CC genotype during the follow-up. Furthermore, differences between genotypes were also observed with the rs509035 SNP for 2-h plasma glucose and fasting insulin in the whole study population when data were analyzed longitudinally (p/q = 0.014/0.035 and p/q = 0.037/0.035, respectively). Changes in parameters of glucose metabolism differed according to rs509035 in the whole study population (fasting plasma glucose: p/q = 0.046/0.086, 2-h plasma glucose: p/q = 0.011/0.069, 2-h serum insulin: p/q = 0.037/0.086) and in the control group separately (2-h plasma glucose: p/q = 0.038/0.267, 2-h serum insulin: p/q = 0.014/0.152), with persons with rs509035-TT genotype showing a decrease in those parameters during the follow-up.
###end p 33
###begin title 34
Glucose metabolism measures according to rs490683 genotypes in DPS.
###end title 34
###begin p 35
###xml 214 225 212 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 252 263 250 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CG</italic>
###xml 289 300 287 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-GG</italic>
###xml 366 368 364 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 373 375 371 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CG</italic>
###xml 387 389 385 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</italic>
###xml 394 396 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 408 410 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CG</italic>
###xml 415 417 413 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 670 681 668 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 696 707 694 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CG</italic>
###xml 724 735 722 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-GG</italic>
A. 2-h plasma glucose according to rs490683 genotypes in all subjects. Mean+/-SEM are estimated marginal means calculated from repeated measures ANOVA with group, age and BMI at baseline as significant covariates. rs490683-CC (n = 42, filled circles); rs490683-CG (n = 171, open circles); rs490683-GG (n = 210, filled triangles). Pair-wise comparisons all subjects: CC vs. CG p = 0.020, CC vs. GG p = 0.295, CG vs. GG p = 0.190. B-E. Relative changes fasting plasma glucose (B), 2-h plasma glucose (C), fasting serum insulin (D) and 2-h serum insulin (E) according to the different genotypes of rs490683 in all subjects and separately in intervention and control group. rs490683-CC (black bars); rs490683-CG (striped bars); rs490683-GG (white bars). The q-value denotes the false discovery rate (FDR) and is reported only for p<0.1. n.s., non-significant.
###end p 35
###begin p 36
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
None of the GHSR polymorphisms were statistically significantly associated with risk of type 2 diabetes (data not shown).
###end p 36
###begin title 37
Differential protein binding in the 5'-regulatory region
###end title 37
###begin p 38
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Cartharius1">[22]</xref>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002941.s001">Table S1</xref>
###xml 760 766 760 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g004">Fig. 4</xref>
###xml 858 869 858 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs6772676-T</italic>
###xml 933 944 933 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs6772676-C</italic>
###xml 966 976 966 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-G</italic>
###xml 1045 1055 1045 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-C</italic>
###xml 1229 1236 1229 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002941-t002">Table 2</xref>
###xml 622 625 <span type="species:ncbi:10116">rat</span>
We used the Genomatix MatInspector software [22] to identify putative transcription factor (TF)-binding sites in the 5'-region (haploblock 1) of the GHSR gene that may be implicated in the regulation of the gene expression. We screened 20 kb upstream of the translation initiation site and identified 8 SNPs that potentially disrupted one or more TF-binding sites in either one of the alleles or both. Subsequently, we tested oligonucleotides containing either of the alleles of each SNP (supplementary Table S1) to identify possible differences in protein binding between the alleles of each SNP in gelshift assays using rat hypothalami as a TF protein source. The SNPs rs6772676 and rs490683 showed different protein binding when both alleles were compared (Fig. 4). Specifically, when the protein binding of the "wild-type" allele was normalized to 100%, rs6772676-T allele showed lower protein binding (only 28%) compared to the rs6772676-C allele. Furthermore, rs490683-G allele showed higher protein binding (745%) compared to that of the rs490683-C allele. The G-allele of rs490683 is present in the core sequence of the putative binding site of the TF nuclear factor 1 (NF-1), which is disrupted when G is replaced by C (Table 2).
###end p 38
###begin title 39
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Differential protein binding of rat hypothalamus nuclear protein extract.
###end title 39
###begin p 40
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 553 555 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</sup>
Gelshift experiments were performed with 32P-labeled oligonucleotides containing one or the other allele of respective single nucleotide polymorphism (SNP). Numbers below the gels indicate the means of three independent experiments with standard deviation (SD) in parenthesis. Protein binding of the "wild-type" allele was normalized to 100%. Representative gels are shown. NS denotes non-specific DNA-protein interactions, which are not due to specific binding between the labelled DNA and the proteins contained in the hypothalamus extract. * p<0.05; ** p<0.001.
###end p 40
###begin title 41
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
Single nucleotide polymorphisms (SNPs) in the GHSR promoter and putative transcription factor (TF) binding sites.
###end title 41
###begin p 42
SNPs genotyped from DPS population.
###end p 42
###begin p 43
different protein binding in gelshift assay.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 270 282 270 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9819506-AA</italic>
###xml 412 423 412 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 573 579 573 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Baessler1">[15]</xref>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 757 767 757 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-C</italic>
###xml 772 782 772 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs509035-T</italic>
###xml 866 877 866 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 1260 1264 1260 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 1282 1286 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Dossus1">[17]</xref>
###xml 1293 1299 1293 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1299 1303 1299 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Wang1">[23]</xref>
###xml 1360 1370 1360 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs495225-T</italic>
###xml 1545 1549 1545 1549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 1322 1330 <span type="species:ncbi:9606">children</span>
We have shown that two SNPs (rs490683 and rs9819506) in the promoter region of the human GHSR gene are associated with the change in body weight and BMI. The GHSR SNP rs9819506, which has not been examined in previous studies, showed an association and individuals with rs9819506-AA genotype showed lowest values for body weight and a trend for lowest BMI during a 3-year follow-up. Interestingly, subjects with rs490683-CC genotype displayed highest weight loss in the whole study group as well as in the intervention group, when assessed separately. Previously, Baessler et al.[15] showed an association between GHSR haplotypes and obesity. The so-called "susceptible" haplotype tested in that study was found more often in obese individuals and included rs490683-C and rs509035-T alleles. These results might be considered contradictory to ours, where we see the rs490683-CC genotype as "beneficial" genotype. However, it is difficult to compare data from a longitudinal intervention study with individuals at high risk of type 2 diabetes describing the effect of the certain genotype on the weight development and a cross-sectional study carried out in a different population. A more recent study, however, could not point out a clear relationship between GHSR SNPs and obesity [17]. Wang et al.[23] showed that obese children and adolescents had a higher rs495225-T allele frequency than underweight subjects, but this trend could not be confirmed in their further studies. Thus, they concluded that there is no evidence for involvement of GHSR SNPs in body weight regulation. In our study, SNPs rs495225 and rs565105 were not unequivocally associated with measures of obesity or type 2 diabetes.
###end p 45
###begin p 46
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 17 21 17 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Vartiainen1">[16]</xref>
###xml 48 59 48 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs495225-CC</italic>
###xml 410 421 410 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 426 437 426 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs509035-TT</italic>
###xml 730 741 730 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 759 770 759 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs509035-TT</italic>
###xml 562 568 <span type="species:ncbi:9606">people</span>
Vartiainen et al.[16] showed that subjects with rs495225-CC genotype had highest area under the insulin curve values and IGFBP-1 concentrations. In the present study, in the DPS population rs6772767, rs490683 and rs509035 were associated with several measures of glucose metabolism over four consecutive measurements. Beneficial changes in glucose metabolism could be observed specifically in individuals with rs490683-CC and rs509035-TT genotypes, especially in the control group. The control group in the DPS trial can be considered as a prospective cohort of people at high risk of diabetes. Since changes in measures of glucose metabolism during the study period were only observed in the control group, it indicates that the rs490683-CC genotype and the rs509035-TT genotype are beneficial or protective genotypes. A reduction in body weight was, however, evident when the whole study population was analysed, but this was mostly explained by the change in the intervention group. This finding is in some discrepancy with the association shown with measures of glucose metabolism. Thus, it might be that the different association with body weight and glucose metabolism are mediated via different mechanisms. In addition, we cannot exclude the impact of the moderate population size contributing to these varying associations. Unfortunately, we do not have the possibility to increase the size of the DPS population, but hopefully in the future it is possible to carry out joint analyses with the data from several other similar type of lifestyle intervention studies. However, we feel that the nature of DPS, as being a longitudinal study with an intensive lifestyle intervention in a carefully phenotyped high risk population, is unique and therefore our results offer valuable contribution and addition to the knowledge about weight and glucose control.
###end p 46
###begin p 47
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
Rs490683 and rs509035 are in strong LD with each other and this may further explain the similar results concerning glucose metabolism phenotypes. Rs509035 is located in the intron of the GHSR gene, thus it was not included in our analysis for putative TF binding sites. Nevertheless, it cannot be excluded that this SNP has functional consequences, but we did not test this. Thus, based on our results we may speculate that rs490683 could be the causal SNP accounting for the effects observed.
###end p 47
###begin p 48
As a limitation we need to point out that due to the distribution of these data, only non-parametric tests could be carried out where adjustments for covariates were not possible. To account for multiple testing and to control false positive rate, or type I error, we calculated the false discovery rate (FDR), expressed as q-value, for given p-values. Associations with a significant p-value, but a high q-value must be cautiously interpreted.
###end p 48
###begin p 49
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 172 181 172 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 659 669 659 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-G</italic>
###xml 719 729 719 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-C</italic>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Gronostajski1">[24]</xref>
###xml 1132 1136 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Borgmeyer1">[25]</xref>
###xml 1157 1161 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Jones1">[26]</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Santoro1">[27]</xref>
###xml 1247 1248 1247 1248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1249 1254 1249 1254 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCAA</named-content>
###xml 1337 1342 1337 1342 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGGC</named-content>
###xml 1346 1351 1346 1351 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCAA</named-content>
###xml 1384 1388 1384 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Gronostajski1">[24]</xref>
###xml 1436 1440 1436 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Gronostajski1">[24]</xref>
###xml 1491 1502 1491 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-GG</italic>
###xml 1683 1687 1683 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Kim1">[28]</xref>
###xml 1733 1744 1733 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-GG</italic>
###xml 1825 1836 1825 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs490683-CC</italic>
###xml 317 320 <span type="species:ncbi:10116">rat</span>
###xml 371 375 <span type="species:ncbi:10116">rats</span>
###xml 463 468 <span type="species:ncbi:9606">human</span>
###xml 565 570 <span type="species:ncbi:9606">human</span>
To test the potential functional relevance of SNPs in the 5'-region of GHSR we first examined the regions where SNPs are possibly disrupting putative TF-binding sites with in silico promoter analysis. We then tested oligonucleotides with each allele of each SNP in gelshift assays using nuclear protein extracts from rat hypothalamus. We chose to use hypothalami of male rats as a comparable protein source, due to the fact that this tissue is unavailable from a human source. The DNA sequences (oligos) used for the gelshift experiments were designed to match the human sequence. We observed that nuclear proteins were binding to the sequence containing the rs490683-G allele with much higher affinity than to that of rs490683-C allele. At this position a putative NF-1 binding site exists and is disrupted by the SNP rs490683, changing the sequence from GCCA to CCCA. The NF-1 family of site-specific DNA-binding proteins functions both as cellular TFs in the regulation of gene expression and as replication factors for adenovirus DNA replication [24]. Binding specificity of NF-1 is equivalent to both the TGGCA-binding protein [25] and the CAAT-box TF [26], [27]. NF-1 protein binds as a dimer to the dyad symmetric consensus sequence TTGGC(N5)GCCAA on duplex DNA, although NF-1 can also bind specifically to individual half sites (TTGGC or GCCAA) with somewhat reduced affinity [24]. NF-1 has been shown to activate transcription [24] and it can be speculated that in individuals with rs490683-GG genotype, where the NF-1 half site is intact, GHSR expression is enhanced, thus potentially leading to an increase in receptor signalling and ultimately to an increase in appetite [28]. In fact, our study shows that subjects with rs490683-GG genotype lost less weight during a lifestyle intervention than individuals with rs490683-CC genotype.
###end p 49
###begin p 50
###xml 110 114 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Holst2">[29]</xref>
###xml 228 231 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Holst1">[7]</xref>
###xml 394 398 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Kim1">[28]</xref>
###xml 524 527 512 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Holst1">[7]</xref>
###xml 533 537 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 626 638 614 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs4906863-GG</italic>
It has been shown recently that GHSR signals with approximately50% activity even in the absence of an agonist [29]. That implies that control of the expression level of the receptor is directly correlated to signalling activity [7]. It has been shown that during prolonged fasting, GHSR expression in the hypothalamus is increased, which could contribute to the amplification of ghrelin action [28] and could be expected to result in a ghrelin-independent increase in receptor signalling and thereby an increase in appetite [7]. The GHSR polymorphism rs490683 was associated with weight change in our study population and the rs4906863-GG genotype, where the NF-1 site is intact, might lead to increased ghrelin receptor expression.
###end p 50
###begin p 51
The alleles of rs519384 did not show differential protein binding, indicating that the SNP is not in an important region for GHSR gene expression. Although rs9819506 was associated with weight and BMI, gelshift assays showed no difference in protein binding between the alleles, which may be due to species differences. Although we could observe a difference in protein binding between the alleles of rs6772676, it cannot explain the observed association with glucose levels.
###end p 51
###begin p 52
###xml 80 86 <span type="species:ncbi:9606">humans</span>
###xml 146 149 <span type="species:ncbi:10116">rat</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 286 289 <span type="species:ncbi:10116">rat</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
###xml 474 480 <span type="species:ncbi:9606">humans</span>
###xml 485 488 <span type="species:ncbi:10116">rat</span>
###xml 679 683 <span type="species:ncbi:10116">rats</span>
###xml 737 741 <span type="species:ncbi:10116">rats</span>
TFs and more importantly their DNA binding domains are highly conserved between humans and rodents. For example, the nucleic acid sequence of the rat NF-1 is 99% identical to the human sequence and on amino acid level there is a 91% overlap between the sequences. The variations in the rat NF-1 protein (compared to the human sequence) are not located within its DNA binding domain, thus they are unlikely to affect its binding to DNA. Due to the tissue unavailability from humans the rat protein extract provides a good model to test for differential protein binding to the alleles because of the high degree of conservation between the two species. We used hypothalami of male rats only, but obviously the autosomes of male and female rats are identical. Only genes located on the Y-chromosome will differ between the two sexes, whereas e.g. NF-1 is located on chromosome 17. Some TFs might show a difference in their expression levels. Thus, the gelshift bands might be stronger or weaker comparing males and females but the clear difference of protein binding to the different SNP alleles will still occur.
###end p 52
###begin p 53
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Loos1">[18]</xref>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Frayling1">[19]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Scott1">[20]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Salonen1">[21]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Zeggini1">[30]</xref>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 570 571 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Hinney1">[31]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Scuteri1">[32]</xref>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Liu1">[33]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Fox1">[34]</xref>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 929 933 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 1134 1138 1134 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 719 724 <span type="species:ncbi:9606">Human</span>
To our knowledge, no GWA study for obesity has been carried out in Finns alone; however, samples from Finnish studies have been used in replication studies (e.g. [18], [19]). The primary GWA studies investigating the genetics of type 2 diabetes are available. The studies regarding type 2 diabetes in Finnish subjects [20], [21], [30] have used the Illumina HumanHap300 Genotyping BeadChips containing over 317,000 SNPs. Two SNPs in the GHSR gene overlap with the SNPs investigated in our study, that is rs9819506 and rs565105. One more SNP, rs10513702, is in high LD (r2 = 0.966) with rs6772676, which was also genotyped in our study. Other GWA studies investigating obesity have used variably the Affymetrix GeneChip Human Mapping 10K, 100K or 500K Array Set [31], [32], [33], [34]. In the 500K Array Set are 6 SNPs of the GHSR gene included and one of those overlaps with the SNPs genotyped in our study (rs509035). The other GHSR SNPs are not in LD with SNPs which we genotyped. In GWA studies stringent quality control criteria are applied for the given setting. Thus it is possible that the few SNPs used in this study from the GHSR gene did not match those criteria (e.g. call rate, Hardy-Weinberg equilibrium for the given study population).
###end p 53
###begin p 54
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
In summary, results of our study suggest that polymorphisms in the GHSR gene are longitudinally associated with obesity and glucose metabolism in a prospective study setting. Genetic variation in the promoter may have an effect on appetite regulation by modulating gene expression of GHSR and subsequently ghrelin receptor signalling. This study is the first to show potential functional consequences of a GHSR SNP. Further studies are warranted to confirm our results and to find SNPs that are causal and have clinical relevance.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
Subjects and study design
###end title 56
###begin p 57
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Eriksson1">[35]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Tuomilehto1">[36]</xref>
###xml 482 483 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 843 847 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-WHO1">[37]</xref>
###xml 485 488 <span type="species:ncbi:9606">men</span>
###xml 493 498 <span type="species:ncbi:9606">women</span>
###xml 853 860 <span type="species:ncbi:9606">persons</span>
###xml 1220 1232 <span type="species:ncbi:9606">participants</span>
###xml 1368 1373 <span type="species:ncbi:9606">human</span>
The Finnish DPS is an intervention study carried out in five centres in Finland (clinical trial reg. no: NCT00518167). The main aim of the study was to assess the efficacy of an intensive individually designed diet and exercise program to prevent or delay the onset of type 2 diabetes in subjects with IGT. The study design, subjects, inclusion and exclusion criteria and intervention program have been described earlier in detail [35], [36]. In brief, 522 overweight (BMI>/=25 kg/m2) men and women aged 40 to 65 years with IGT participated in the study. DNA samples were available from 507 individuals (intervention group 259 and control group 248 subjects). IGT was defined as a 2-h plasma glucose concentration of 7.8 to 11.0 mmol/l (oral glucose tolerance test [OGTT] 75 g) with a fasting plasma glucose concentration less than 7.8 mmol/l [37]. The persons enrolled in the study were randomly assigned to one of the two treatment modalities, the intervention group or the conventional care control group. The study protocol was approved by the Ethics Committee of the National Public Health Institute in Helsinki, Finland, and conducted in accordance with the guidelines proposed in the Declaration of Helsinki. All participants gave written informed consent. We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research.
###end p 57
###begin title 58
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
Selection of GHSR SNPs and genotype analysis
###end title 58
###begin p 59
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Altshuler1">[38]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Wheeler1">[39]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Hubbard1">[40]</xref>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002941-g001">Fig. 1A</xref>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GHSR</italic>
###xml 890 898 890 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
For selection of GHSR SNPs for genotype analysis the HapMap [38], NCBI [39] and Ensembl [40] databases were used. Originally, six tag SNPs from two haploblocks covering 15 kb of the gene including three SNPs in haploblock 1 in the 5' end of the gene (rs474225, rs490683 (alternative name in HapMap rs863441), rs9819506), and three SNPs in haploblock 2, one in the coding region in exon 1 leading to a synonymous amino acid substitution (rs495225), one in the intron (rs509035) and one in the 3' end of the GHSR gene (rs565105) were selected (Fig. 1A). In addition, all SNPs in haploblock 1 in the 5' regulatory region (spanning over 17 kb, chr 3: 173648897-17365897; NCBI accession number for GHSR NM_198407.1) available in the HapMap database and located in putative TF-binding sites were tested for their functionality in gelshift experiments. SNPs which showed different protein binding in vitro were genotyped additionally (rs6772676).
###end p 59
###begin p 60
Genotyping was performed with TaqMan Allelic Discrimination Assays (Applied Biosystems, Foster City, CA, USA). The PCR amplification was performed in a GeneAmp PCR system 2700 (Applied Biosystems, Foster City, CA, USA) in following conditions: 95degreesC for 10 min and 40 cycles of denaturation 92degreesC for 15 sec and annealing/extension 60degreesC for 1 min. Allele-specific fluorescence was detected on an ABI Prism 7000 sequence detector. A subset of randomly selected samples representing 6.3% of the study cohort was repeated.
###end p 60
###begin title 61
Promoter analysis
###end title 61
###begin p 62
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Cartharius1">[22]</xref>
In silico promoter analysis of the sequences containing all SNPs in haploblock 1 for putative TF-binding sites was performed using Genomatix MatInspector Release professional 7.4.8.2 [22]. We determined all SNPs that lie in possible TF-binding sites and consequently all TF-binding sites that are disrupted by either one of each SNP allele. We used a threshold of 0.75 for core similarity and the optimized setting for matrix similarity.
###end p 62
###begin title 63
Protein extraction
###end title 63
###begin p 64
###xml 189 190 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 613 614 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 26 45 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Hypothalami of three male Sprague-Dawley rats (supplier Harlan, Netherlands) were pooled and the frozen tissue was homogenized in 0.5 ml of low salt buffer (10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 50 mM KCl, 0.5 mM dithiothreitol, proteinase inhibitors) using a rotor-stator homogenizer (ART Labortechnik, Mullheim, Germany). Cells were then resuspended in 2-3 packed volumes of the same low salt buffer with 0.5% Nonidet P-40 and homogenized by pipetting on ice. The nuclear pellet was subsequently resuspended in one packed cell volume of high salt buffer (10 mM Hepes, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, proteinase inhibitors). Extraction was performed for 30 min on ice.
###end p 64
###begin title 65
Gelshift assay
###end title 65
###begin p 66
###xml 291 293 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 416 424 408 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002941.s001">Table S1</xref>
Gelshift assays were performed with 10 microg protein of the nuclear extracts. The proteins were incubated for 15 min in a total volume of 20 microl of binding buffer (150 mM KCl, 1 mM dithiothreitol, 25 ng/ml herring sperm DNA, 5% glycerol, 10 mM Hepes, pH 7.9). Constant amounts (1 ng) of 32P-labeled double-stranded oligonucleotides (50,000 cpm) containing either one of the respective SNP alleles (supplementary Table S1) were then added, and incubation was continued for 20 min at room temperature. Protein-DNA complexes were resolved by electrophoresis in 8% non-denaturing polyacrylamide gels (mono- to bisacrylamide ratio 19:1) in 0.5xTBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA, pH 8.3) for 90 min at 200 V and quantified on a FLA-3000 reader (Fuji, Tokyo, Japan) using ScienceLab99 software (Fuji).
###end p 66
###begin title 67
Statistical analysis
###end title 67
###begin p 68
###xml 1865 1869 1865 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Storey1">[41]</xref>
###xml 1873 1874 1872 1873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 2337 2341 2329 2333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Barrett1">[42]</xref>
The significances of differences in genotype and allele frequencies were analyzed using a chi-square test and a two-sided Fisher's exact test, respectively. Normal distributions were tested with the Kolmogorov-Smirnov test with Lilliefors correction. To normalize the skewed distributions, logarithmic transformations or reciprocal transformations were applied when needed. The differences in continuous variables between genotypes of single SNPs at baseline were evaluated with the general linear model (GLM) for the univariate analysis of variance (ANOVA). Biochemical measurements were adjusted for age, sex and BMI as main effects and weight-related variables for age and sex only. When variables could not be transformed to be normally distributed, Kruskal-Wallis test was used. GLM repeated measures ANOVA was used to analyze differences between genotypes of each SNP during the follow-up period concerning obesity-related and insulin- and glucose-metabolism related phenotypes. A final model was built manually with a backward selection procedure with following covariates included: age at baseline, sex, study group and BMI at baseline, as appropriate. Genotype*group interaction was tested and groups were analyzed separately if the interaction term was statistically significant. P-values are for trend between all three genotype groups and pairwise comparisons based on estimated marginal means were adjusted for multiple comparisons with Bonferroni correction. Relative changes in weight and measures of glucose and insulin metabolism from baseline to year 3 were analyzed with Kruskal-Wallis test, because data were not normally distributed even after applying several transformations. A p-value of 0.05 or lower was considered statistically significant. Correction for multiple hypothesis testing was performed with FDR using the Q-value 1.0 software [41]. pi0 was estimated with bootstrap method using a lambda range from 0 to 0.9 by 0.05. The FDR for each p-value is reported as q-value. The q-value threshold is the proportion of significant features that turn out to be false leads. Data are given as means+/-SD, unless otherwise stated. All data were analyzed using SPSS for Windows 14.0 (SPSS Inc., Chicago, IL, USA). LD statistics were calculated and haplotype blocks were visualized by using the Haploview software [42].
###end p 68
###begin title 69
Supporting Information
###end title 69
###begin p 70
Oligonucleotides used in gelshift assays. List of oligonucleotides which were used to test the difference in protein binding among different GHSR SNP alleles.
###end p 70
###begin p 71
(0.04 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 63 66 <span type="species:ncbi:10116">rat</span>
We thank Dr. Jari Nissinen and Dr. Maria Vlasova for providing rat hypothalami.
###end p 73
###begin p 74
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Eriksson1">[35]</xref>
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002941-Tuomilehto1">[36]</xref>
###xml 157 163 <span type="species:ncbi:9606">people</span>
The DPS group has been previously described in the earlier publications [35], [36]. The Finnish Diabetes Prevention Group consists additionally of following people: Timo Valle, Helena Hamalainen, Pirjo Ilanne-Parikka, Sirkka Keinanen-Kiukaanniemi.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
Gut hormones and the regulation of energy homeostasis.
###end article-title 76
###begin article-title 77
Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
###end article-title 77
###begin article-title 78
Ghrelin: structure and function.
###end article-title 78
###begin article-title 79
Ghrelin: an orexigenic and somatotrophic signal from the stomach.
###end article-title 79
###begin article-title 80
Ghrelin induces adiposity in rodents.
###end article-title 80
###begin article-title 81
A role for ghrelin in the central regulation of feeding.
###end article-title 81
###begin article-title 82
Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation.
###end article-title 82
###begin article-title 83
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat.
###end article-title 83
###begin article-title 84
A receptor in pituitary and hypothalamus that functions in growth hormone release.
###end article-title 84
###begin article-title 85
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
###end article-title 85
###begin article-title 86
###xml 87 93 <span type="species:ncbi:9606">humans</span>
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.
###end article-title 86
###begin article-title 87
###xml 69 74 <span type="species:ncbi:9606">human</span>
GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils.
###end article-title 87
###begin article-title 88
###xml 87 92 <span type="species:ncbi:9606">human</span>
Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells.
###end article-title 88
###begin article-title 89
###xml 0 4 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
Mice lacking ghrelin receptors resist the development of diet-induced obesity.
###end article-title 89
###begin article-title 90
###xml 103 108 <span type="species:ncbi:9606">human</span>
Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity.
###end article-title 90
###begin article-title 91
Sequencing analysis of the ghrelin receptor (growth hormone secretagogue receptor type 1a) gene.
###end article-title 91
###begin article-title 92
Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
###end article-title 92
###begin article-title 93
Common variants near MC4R are associated with fat mass, weight and risk of obesity.
###end article-title 93
###begin article-title 94
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
###end article-title 94
###begin article-title 95
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 95
###begin article-title 96
Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium.
###end article-title 96
###begin article-title 97
MatInspector and beyond: promoter analysis based on transcription factor binding sites.
###end article-title 97
###begin article-title 98
###xml 86 94 <span type="species:ncbi:9606">children</span>
###xml 164 172 <span type="species:ncbi:9606">children</span>
Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature.
###end article-title 98
###begin article-title 99
Roles of the NFI/CTF gene family in transcription and development.
###end article-title 99
###begin article-title 100
The TGGCA-binding protein: a eukaryotic nuclear protein recognizing a symmetrical sequence on double-stranded linear DNA.
###end article-title 100
###begin article-title 101
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.
###end article-title 101
###begin article-title 102
###xml 12 17 <span type="species:ncbi:9606">human</span>
A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs.
###end article-title 102
###begin article-title 103
Changes in ghrelin and ghrelin receptor expression according to feeding status.
###end article-title 103
###begin article-title 104
High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist.
###end article-title 104
###begin article-title 105
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
###end article-title 105
###begin article-title 106
Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants.
###end article-title 106
###begin article-title 107
Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.
###end article-title 107
###begin article-title 108
Genome-wide association scans identified CTNNBL1 as a novel gene for obesity.
###end article-title 108
###begin article-title 109
Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project.
###end article-title 109
###begin article-title 110
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.
###end article-title 110
###begin article-title 111
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
###end article-title 111
###begin article-title 112
Diabetes mellitus. Report of a WHO Study Group.
###end article-title 112
###begin article-title 113
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome.
###end article-title 113
###begin article-title 114
Database resources of the National Center for Biotechnology Information.
###end article-title 114
###begin article-title 115
Ensembl 2007.
###end article-title 115
###begin article-title 116
Statistical significance for genomewide studies.
###end article-title 116
###begin article-title 117
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work has been financially supported by grants from the Academy of Finland (number 209445 to MK, numbers 40758 and 117844 to MU; numbers 38387 and 46558 to JT), the EVO-fund of Kuopio University Hospital (numbers 5179, 5198, 5952 and 5926 to MU), the Ministry of Education of Finland, the Finnish Diabetes Foundation, Sigrid Juselius Foundation, the Austrian Academy of Sciences, the RTN NucSys of the European Union, the Finnish Graduate School on Applied Bioscience and the Yrjo Jahnsson Foundation.
###end p 119

